09:45?0 American Diabetes Association. Standards of medical care in diabetesd2011. Diabetes Care 2011;34(Suppl. 1):S11 61 KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Illness. Am J Kidney Dis 2007;49(Suppl. two):S12?S154 Bonifacio E, Yu L, Williams AK, et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases consortia. J Clin Endocrinol Metab 2010;95: 3360?367 Dabelea D, D’Agostino RB Jr, Mason CC, et al. Improvement, validation and use of an insulin sensitivity score in youths with diabetes: the Search for Diabetes in Youth study. Diabetologia 2011;54:78?86 Dabelea D, Pihoker C, Talton JW, et al.; Search for Diabetes in Youth Study. Etiological strategy to characterization of diabetes type: the Search for Diabetes in Youth Study. Diabetes Care 2011;34: 1628?633 Teupe B, Bergis K. Epidemiological proof for “double diabetes.” Lancet 1991; 337:361?62 Chillar JJ, Goday A, Flores-Le-Roux JA, et al. Estimated glucose disposal price in assessment of your metabolic syndrome and microvascular complications in individuals with sort 1 diabetes. J Clin Endocrinol Metab 2009;94:3530?534 Olson JC, Erbey JR, Williams KV, et al. Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in kind 1 diabetes. Ann Epidemiol 2002;12:331?37 Rowley KG, Iser DM, Best JD, O’Dea K, Leonard D, McDermott R. Albuminuria in14.15.16.17.18. 19.20.21.22.23. 24.References 1. Pugh JA, Medina R, Ramirez M. Comparison in the course to end-stage renal disease of sort 1 (insulin-dependent) and form 2 (non-insulin-dependent) diabetic nephropathy. Diabetologia 1993;36:1094?care.diabetesjournals.org25.26.DIABETES CARE, VOLUME 36, NOVEMBERAlbuminuria amongst youthAustralian Aboriginal people today: prevalence and associations with components on the metabolic syndrome. Diabetologia 2000; 43:1397?403 27. Mykk en L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998;47:793?00 28. Nosadini R, Cipollina MR, Solini A, et al. Close partnership among microalbuminuria and insulin resistance in vital hypertension and non-insulin dependent diabetes mellitus. J Am Soc Nephrol 1992;3(Suppl.):S56 63 29. Bonnet F, Marre M, Halimi JM, et al.Methyl (S)-3-bromo-2-methylpropanoate site ; DESIR Study Group.(5-Bromopyrazin-2-yl)methanol Chemical name Waist circumference and also the metabolic syndrome predict the improvement of elevated albuminuria in non-diabetic subjects: the DESIR Study.PMID:32261617 J Hypertens 2006;24:1157?163 Diez-Sampedro A, Lenz O, Fornoni A. Podocytopathy in diabetes: a metabolic and endocrine disorder. Am J Kidney Dis 2011;58:637?46 Welsh GI, Coward RJ. Podocytes, glucose and insulin. Curr Opin Nephrol Hypertens 2010;19:379?84 Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008;34:two?1 Kang YS, Song HK, Lee MH, et al. Visfatin is upregulated in type-2 diabetic rats and targets renal cells. Kidney Int 2010;78: 170?81 Fioretto P, Stehouwer CD, Mauer M, et al. Heterogeneous nature of microalbuminuria in NIDDM: research of endothelial function and renal structure. Diabetologia 1998;41: 233?36 Brandt JR, Jacobs A, Raissy HH, et al. Orthostatic proteinuria plus the spectrum of diurnal variability of urinary protein excretion in healthier youngsters. Pediatr N.